Danaparoid (Orgaran®) for the treatment of heparin-indu-ced thrombocytopenia (HIT) and thrombosis: effects on in vivo thrombin and cross-linked fibrin generation, and evaluation of the clinical significance of in vitro cross-reactivity (XR) of danaparoid for HIT-IgG (abstract) - Warkentin, TE (Blood, 1996)
(Suppl 1)